Health Catalyst Inc

Health Catalyst Inc

HCAT · NASDAQ · Healthcare / Health Information Services

1.51USD+0.15 (+11.03%)

Price History

Full chart

Market Stats

Previous Close1.36
Open1.37
Day Range1.36 – 1.55
52-Week Range0.9551 – 3.62
Volume465.29K
Market Cap130.95M
P/E (TTM)0.00
Forward P/E10.00
EPS-3.73
Dividend Yield0.00%
Beta1.53
50-Day Avg1.87
200-Day Avg1.81

About

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, accountable care organizations, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Company Details

  • SectorHealthcare
  • IndustryHealth Information Services
  • CEOMr. Benjamin Albert
  • Employees1.20K
  • Headquarters10897 South River Front Parkway, South Jordan, UT, United States, 84095, USA
  • Websitehttps://www.healthcatalyst.com

Leadership

  • Mr. Benjamin AlbertCEO & Director · b. 1973
  • Mr. Jason AlgerChief Financial Officer · b. 1984
  • Mr. Benjamin LandryGeneral Counsel & Secretary of the Board · b. 1982
  • Mr. Kyle J. SalyersChief Strategy Officer & Senior VP of Corporate Development
  • Ms. Carrie Kozlowski OTChief Marketing Officer
  • Mr. Jeffrey P. SelanderSenior Vice President of International
  • Ms. Holly RimmaschSenior VP & Chief Clinical Officer
  • Ms. Sadiqa Mahmood D.D.S., M.P.H.GM & Senior VP of Life Sciences Business
  • Kristen BerrySenior Vice President of Public Relations
  • Mr. Ryan BarryChief Operating Officer of Professional Services

Financials

Income Statement

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue73.08M112.57M154.94M188.84M241.93M276.24M295.94M306.58M311.14M
Growth (%)-+54.04%+37.63%+21.88%+28.11%+14.18%+7.13%+3.60%+1.48%
Cost of Revenue43.64M59.85M75.34M98.08M124.35M143.05M164.10M165.81M207.00M
Gross Profit29.44M52.72M79.60M90.77M117.57M133.19M131.83M140.78M104.13M
Gross Margin40.28%46.83%51.37%48.06%48.60%48.21%44.55%45.92%33.47%
Operating Expense74.98M112.82M134.46M186.89M261.22M273.19M258.73M210.59M140.24M
Operating Income-45.54M-60.09M-54.87M-96.13M-143.65M-140.00M-126.90M-69.81M-36.10M
Operating Margin-62.31%-53.38%-35.41%-50.90%-59.38%-50.68%-42.88%-22.77%-11.60%
EBITDA-39.75M-52.12M-47.32M-85.91M-101.68M-82.92M-68.28M-10.65M-110.35M
EBITDA Margin-54.39%-46.30%-30.54%-45.49%-42.03%-30.02%-23.07%-3.47%-35.47%
Net Income-47.03M-61.98M-60.10M-115.02M-153.21M-137.40M-118.15M-69.50M-177.97M
Net Income Margin-64.36%-55.06%-38.79%-60.91%-63.33%-49.74%-39.92%-22.67%-57.20%
R&D28.47M38.59M46.25M53.52M62.73M75.68M72.63M57.95M49.77M
R&D as % of Total Revenue38.96%34.28%29.85%28.34%25.93%27.40%24.54%18.90%16.00%
Interest Expense2.01M2.59M6.26M13.72M17.31M7.24M7.29M17.09M16.40M
Interest Expense % of Total Revenue2.75%2.30%4.04%7.26%7.16%2.62%2.46%5.57%5.27%

Balance Sheet

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets110.27M110.97M302.36M577.74M832.10M752.29M701.81M858.93M502.64M
Total Liabilities369.74M485.74M101.72M301.64M310.00M327.28M334.89M493.72M256.86M
Total Equity-259.48M-374.77M200.64M276.10M522.10M425.01M366.92M365.21M245.78M
Cash22.98M28.43M18.03M91.95M193.23M116.31M106.28M249.65M50.81M
Total Debt12.62M26.91M52.66M195.28M204.61M247.97M249.07M402.26M171.24M
Net Debt-10.35M-1.52M34.63M103.33M11.38M131.66M142.79M152.62M120.42M

Cash Flow

Currency: USD2017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-36.83M-40.30M-32.18M-26.15M-23.12M-35.27M-33.08M14.56M731.00K
Investing Cash Flow22.41M21.40M-209.60M-82.56M-139.68M-39.02M20.29M-22.90M36.19M
Financing Cash Flow24.87M24.35M231.38M182.61M264.08M-2.61M2.73M151.75M-235.78M
Capital Expenditure3.34M2.50M4.33M10.46M18.47M17.41M14.31M16.40M968.00K
Free Cash Flow-40.17M-42.80M-36.52M-36.61M-41.59M-52.68M-47.39M-1.84M-237.00K
Dividends Paid00-------
FCF to OCF109.08%106.21%113.47%140.02%179.86%149.37%143.26%-12.63%-32.42%
Dividend Paid to FCF0.00%0.00%-------

Earnings

Report DateApr 10, 2019Aug 22, 2019Nov 12, 2019Feb 27, 2020May 12, 2020Aug 11, 2020Nov 10, 2020Feb 25, 2021May 6, 2021Aug 5, 2021Nov 9, 2021Mar 1, 2022May 10, 2022Aug 5, 2022Nov 8, 2022Feb 28, 2023May 9, 2023Aug 8, 2023Nov 2, 2023Feb 22, 2024May 10, 2024Aug 7, 2024Nov 6, 2024Feb 20, 2025May 7, 2025Aug 7, 2025Nov 10, 2025Mar 13, 2026May 11, 2026Aug 6, 2026Nov 9, 2026
EPS Estimate0.00-0.32-0.37-0.29-0.26-0.22-0.27-0.19-0.14-0.14-0.22-0.21-0.11-0.09-0.19-0.11-0.04-0.01-0.01-0.010.030.080.090.080.03-0.090.070.100.01-0.05-0.07
EPS Actual-2.17-0.21-0.27-0.21-0.16-0.15-0.21-0.16-0.06-0.00-0.18-0.19-0.06-0.03-0.13-0.050.050.050.030.020.050.120.070.040.01-0.080.060.080.02-0.08-
Surprise-34.38%27.03%27.59%38.46%31.82%22.22%15.79%57.14%98.79%18.18%9.52%45.45%66.67%31.58%54.55%225.00%600.00%400.00%300.00%66.67%50.00%-22.22%-47.64%-66.67%11.11%-14.29%-16.14%100.00%-60.00%-
Timing-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap130.95M
Enterprise Value196.81M
Trailing P/E0.00
Forward P/E10.00
Price / Sales0.45
Price / Book1.29
EPS-3.73
Book Value1.35
Revenue (TTM)292.24M
Gross Profit (TTM)149.52M
EBITDA11.77M
Profit Margin-90.62%
Operating Margin-5.35%
Return on Equity-118.12%
Return on Assets-3.02%
Shares Outstanding75.26M
Shares Float59.27M
Beta1.53
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 13 analystsTarget 1.83
  • Strong Buy
    7
  • Buy
    2
  • Hold
    4

Ownership Breakdown

Institutions
71.51%
Insiders
5.66%
Retail / Other
22.83%

Top Institutional Holders

  • First Light Asset Management, LLC
    12.81M17.02%
  • CDC Financial, Inc.
    7.09M9.42%
  • BlackRock Inc
    5.14M6.83%
  • Impax Asset Management Group PLC
    4.00M5.32%
  • Nepsis, Inc.
    2.98M3.95%
  • Palogic Value Management LP
    2.90M3.85%
  • Vanguard Capital Management, LLC
    2.89M3.83%
  • Geode Capital Management, LLC
    1.50M2.00%
  • State Street Corp
    1.32M1.76%
  • Dimensional Fund Advisors, Inc.
    911.82K1.21%
  • Caption Management, LLC
    771.89K1.03%
  • Mink Brook Asset Management LLC
    738.28K0.98%
  • Prescott Group Capital Management LLC
    710.80K0.94%
  • JPMorgan Chase & Co
    677.95K0.90%
  • Charles Schwab Investment Management Inc
    606.86K0.81%
  • AQR Capital Management LLC
    543.24K0.72%
  • Vanguard Portfolio Management, LLC
    531.01K0.71%
  • Millennium Management LLC
    516.08K0.69%

Top Fund Holders

  • Impax Small Cap Institutional
    4.00M5.32%
  • Vanguard MStar Total Stk Mkt Idx Invest
    2.06M2.73%